Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Multicentric Epithelioid Angiosarcoma of Bone

View through CrossRef
Bone epithelioid angiosarcoma is rare and generally shows positive immunostaining for epithelial markers. Multicentric bone epithelioid angiosarcoma is easily misdiagnosed as carcinoma, including metastatic carcinoma, multiple myeloma, and multiple lymphoma of bone. This article describes a case of multicentric bone epithelioid angiosarcoma. The patient was first misdiagnosed as having metastatic carcinoma. Examination showed osteolytic lesions in the bilateral heels and the lower left humerus. The diagnosis was confirmed postoperatively and corrected after immunohistochemical analysis of the biopsy. The immunohistochemical analysis revealed that the tumor mass was strongly positive for CD31, factor VIII, vimentin, and neuron-specific enolase. The patient refused chemotherapy and died of lung metastasis 4 months postoperatively. Most bone epithelioid angiosarcomas are immunopositive for epithelial markers (ie, keratin, cytokeratin, high-molecular-weight keratin, and epithelial membrane antigen), vascular endothelial markers (ie, CD31, CD34, and von Willebrand factor), and factor VIII–associated antigen. Bone epithelioid angiosarcoma shows a relatively high degree of malignancy. Patients often die of distant metastasis, including those found in the lung and lymph node tissue. A wide excision of epithelioid angiosarcoma should be performed during the operation of the primary tumor. A better understanding of the clinicopathologic features of this disease may help to clarify the confusion, provide better treatment, and improve the clinical prognosis.
Title: Multicentric Epithelioid Angiosarcoma of Bone
Description:
Bone epithelioid angiosarcoma is rare and generally shows positive immunostaining for epithelial markers.
Multicentric bone epithelioid angiosarcoma is easily misdiagnosed as carcinoma, including metastatic carcinoma, multiple myeloma, and multiple lymphoma of bone.
This article describes a case of multicentric bone epithelioid angiosarcoma.
The patient was first misdiagnosed as having metastatic carcinoma.
Examination showed osteolytic lesions in the bilateral heels and the lower left humerus.
The diagnosis was confirmed postoperatively and corrected after immunohistochemical analysis of the biopsy.
The immunohistochemical analysis revealed that the tumor mass was strongly positive for CD31, factor VIII, vimentin, and neuron-specific enolase.
The patient refused chemotherapy and died of lung metastasis 4 months postoperatively.
Most bone epithelioid angiosarcomas are immunopositive for epithelial markers (ie, keratin, cytokeratin, high-molecular-weight keratin, and epithelial membrane antigen), vascular endothelial markers (ie, CD31, CD34, and von Willebrand factor), and factor VIII–associated antigen.
Bone epithelioid angiosarcoma shows a relatively high degree of malignancy.
Patients often die of distant metastasis, including those found in the lung and lymph node tissue.
A wide excision of epithelioid angiosarcoma should be performed during the operation of the primary tumor.
A better understanding of the clinicopathologic features of this disease may help to clarify the confusion, provide better treatment, and improve the clinical prognosis.

Related Results

Poster 107: The Use of Coacervate Sustained Release System to Identify the Most Potent BMP for Bone Regeneration
Poster 107: The Use of Coacervate Sustained Release System to Identify the Most Potent BMP for Bone Regeneration
Objectives: Bone morphogenetic proteins (BMPs) belong to the transforming growth factor superfamily that were first discovered by Marshall Urist. There are 14 BMPs identified to da...
Personalized Treatment for Scalp Angiosarcoma
Personalized Treatment for Scalp Angiosarcoma
Cutaneous angiosarcoma is a rare and aggressive malignant tumor that originates from the endothelial cells of blood vessels or lymphatic vessels. More than half of cutaneous angios...
Data from NUP160–SLC43A3 Is a Novel Recurrent Fusion Oncogene in Angiosarcoma
Data from NUP160–SLC43A3 Is a Novel Recurrent Fusion Oncogene in Angiosarcoma
<div>Abstract<p>Angiosarcoma is a malignant vascular tumor originating from endothelial cells of blood vessels or lymphatic vessels. The specific driver mutations in an...
Data from NUP160–SLC43A3 Is a Novel Recurrent Fusion Oncogene in Angiosarcoma
Data from NUP160–SLC43A3 Is a Novel Recurrent Fusion Oncogene in Angiosarcoma
<div>Abstract<p>Angiosarcoma is a malignant vascular tumor originating from endothelial cells of blood vessels or lymphatic vessels. The specific driver mutations in an...
Case Report: A case of primary intracranial parasagittal meningeal angiosarcoma
Case Report: A case of primary intracranial parasagittal meningeal angiosarcoma
Abstract Background Angiosarcoma, also known as malignant hemangioendothelioma, is a rare vasogenic malignant tumor, commonly found on the skin of the head and nec...
Case Report: A case of primary intracranial parasagittal meningeal angiosarcoma
Case Report: A case of primary intracranial parasagittal meningeal angiosarcoma
Abstract Background: Angiosarcoma, also known as malignant hemangioendothelioma, is a rare vasogenic malignant tumor, commonly ...
The irradiated human mandible
The irradiated human mandible
Mandibular bone is known to be susceptible to irradiation damage, especially when radiation dose exceeds 50 Gy. This can result in compromised wound healing and ultimately osteorad...
Efficiency of guided bone regeneration in vertical bone augmentation with titanium-reinforced PTFE membrane and platelet-rich fibrin
Efficiency of guided bone regeneration in vertical bone augmentation with titanium-reinforced PTFE membrane and platelet-rich fibrin
Objective: Guided bone regeneration (GBR) for vertical bone augmention is an easy-to-implement approach and has a good prognosis. However, there are many different procedures that ...

Back to Top